The French health system is relatively expensive at 11.8 percent of G.D.P., while Australia’s is at 9 percent. Access and quality are excellent in both systems. Our pick: France, 4-1.

Given that health system mega M&A is evolving into capability-based scale and Risant’s initiative sounds rather fuzzy, things could get pretty creative.